Clinical Cooperation Group Prediction and Subclassification of Type-2-Diabetes mellitus
Although the number of people suffering from diabetes worldwide is increasing continually at a rapid rate, to date the pathomechanisms of the disease are only poorly understood. For this reason there are no causal therapies available. The mission of the Diabetes Center of Ludwig-Maximilians-Universität Munich is to elucidate the central mechanisms of islet cell dysfunction and beta cell regeneration in order to develop new strategies for the prevention and treatment of diabetes mellitus. The focus of the experimental work is on cell replacement therapy for type 1 diabetes through the transplantation of transgenic pig islet cells and progenitor cells from pluripotent adult stem cells. The aim of the clinical cooperation group Prediction and Subclassification of Type 2 Diabetes mellitus (KKG SK) is to identify biomarkers that enable the three aspects of early detection: to detect an increased risk for type 2 diabetes already in individuals with a normal glucose metabolism, to differentiate between forms of diabetes and to predict the individual course of the disease.
Head: Prof. Dr. Jochen Seißler
Link to website: Clinical Cooperation Group Prediction and Subclassification of Type-2-Diabetes mellitus